COVID-19: fighting the invisible enemy with microRNAs

References

• Chang L, Yan Y, Wang L. Coronavirus disease 2019: coronaviruses and blood safety. Transfus Med Rev. 2020;34:75–80.
   PubMed Web of Science ®Google Scholar
• Ren LL, Wang YM, Wu ZQ, et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl). 2020;133(9):1015–1024.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
   PubMed Web of Science ®Google Scholar
• Peeri NC, Shrestha N, Rahman MS, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol. 2020;49:717–726.
   PubMed Web of Science ®Google Scholar
• Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433.
   PubMed Web of Science ®Google Scholar
• Bogoch II, Watts A, Thomas-Bachli A, et al. Pneumonia of unknown aetiology in Wuhan. J Travel Med. 2020;27:2.
   Web of Science ®Google Scholar
• Lu H, Stratton CW, Tang Y-W. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020;92(4):401–402.
   PubMed Web of Science ®Google Scholar
• Shu Y, GISAID MJ. Global initiative on sharing all influenza data - from vision to reality. Euro Surveill. 2017;22:13.
   Google Scholar
• Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273.
   PubMed Web of Science ®Google Scholar
• Tyrrell DA, Bynoe ML. Cultivation of viruses from a high proportion of patients with colds. Lancet. 1966;1(7428):76–77.
   PubMed Web of Science ®Google Scholar
• Hasan MM, Akter R, Ullah MS, et al. Approach for predicting role of human microRNAs in MERS-CoV genome. Adv Bioinformatics. 2014;967946:2014.
   Google Scholar
• Giovanetti M, Benvenuto D, Angeletti S, et al. The first two cases of 2019-nCoV in Italy: where they come from? J Med Virol. 2020;92(5):518–521.
   PubMed Web of Science ®Google Scholar
• Paraskevis D, Kostaki EG, Magiorkinis G, et al. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol. 2020;79:104212.
   PubMed Web of Science ®Google Scholar
• Banerjee A, Kulcsar K, Misra V, et al. Bats and Coronaviruses. Viruses. 2019;11:1.
   Web of Science ®Google Scholar
• Li W, Shi Z, Yu M, et al. Bats are natural reservoirs of SARS-like coronaviruses. Science. 2005;310(5748):676–679.
   PubMed Web of Science ®Google Scholar
• Hampton T. Bats may be SARS reservoir. Jama. 2005;294(18):2291.
   PubMed Web of Science ®Google Scholar
• Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199–1207.
   PubMed Web of Science ®Google Scholar
• Carlos WG, Dela Cruz CS, Cao B, et al. Novel Wuhan (2019-nCoV) Coronavirus. Am J Respir Crit Care Med. 2020;201(4):P7–p8.
   PubMed Web of Science ®Google Scholar
• Wu P, Hao X, Lau EHY, et al. Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020. Euro Surveill. 2020;25:3.
   Google Scholar
• Wan Y, Shang J, Graham R, et al. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020;94:7.
   Web of Science ®Google Scholar
• Jaimes JA, Millet JK, Stout AE, et al. Tale of two viruses: the distinct spike glycoproteins of feline coronaviruses. Viruses. 2020;12:1.
   Web of Science ®Google Scholar
• Matsuyama S, Nao N, Shirato K, et al. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc Natl Acad Sci U S A. 2020;117(13):7001–7003.
   PubMed Web of Science ®Google Scholar
• Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV Infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382(10):970–971.
   PubMed Web of Science ®Google Scholar
• Nassar MS, Bakhrebah MA, Meo SA, et al. Middle east respiratory syndrome coronavirus (MERS-CoV) infection: epidemiology, pathogenesis and clinical characteristics. Eur Rev Med Pharmacol Sci. 2018;22(15):4956–4961.
   PubMed Web of Science ®Google Scholar
• Malave A, Elamin EM. Severe acute respiratory syndrome (SARS)-lessons for future pandemics. Virtual Mentor. 2010;12(9):719–725.
   PubMedGoogle Scholar
• Lin MH, Chuang SJ, Chen CC, et al. Structural and functional characterization of MERS coronavirus papain-like protease. J Biomed Sci. 2014;21(1):54.
   PubMedGoogle Scholar
• Azhar EI, El-Kafrawy SA, Farraj SA, et al. Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med. 2014;370(26):2499–2505.
   PubMed Web of Science ®Google Scholar
• van Doremalen N, Miazgowicz KL, Milne-Price S, et al. Host species restriction of middle east respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4. J Virol. 2014;88(16):9220–9232.
   PubMed Web of Science ®Google Scholar
• Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350–355.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297.
   PubMed Web of Science ®Google Scholar
• Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006;6(4):259–269.
   PubMed Web of Science ®Google Scholar
• Serban M, Ghiorghiu I, Craciunescu I, et al. Spontaneous echo contrast of unexpected etiology. Eur J Echocardiogr. 2006;7(3):257–259.
   PubMed Web of Science ®Google Scholar
• Miao C, Chang J, Zhang G, et al. MicroRNAs in type 1 diabetes: new research progress and potential directions. Biochem Cell Biol. 2018;96(5):498–506.
   PubMedGoogle Scholar
• Perkins DO, Jeffries CD, Jarskog LF, et al. microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol. 2007;8(2):R27.
   PubMed Web of Science ®Google Scholar
• Sonkoly E, Wei T, Janson PC, et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PloS One. 2007;2(7):e610.
   PubMed Web of Science ®Google Scholar
• Latronico MV, Catalucci D, Condorelli G. Emerging role of microRNAs in cardiovascular biology. Circ Res. 2007;101(12):1225–1236.
   PubMed Web of Science ®Google Scholar
• Janssen HL, Reesink HW, Lawitz EJ, et al. Treatment of HCV infection by targeting microRNA. N Engl J Med. 2013;368(18):1685–1694.
   PubMed Web of Science ®Google Scholar
• Li Y, Xu J, Chen H, et al. Comprehensive analysis of the functional microRNA–mRNA regulatory network identifies miRNA signatures associated with glioma malignant progression. Nucleic Acids Res. 2013;41(22):e203–e203.
   PubMed Web of Science ®Google Scholar
• Cui FM, Li JX, Chen Q, et al. Radon-induced alterations in micro-RNA expression profiles in transformed BEAS2B cells. J Toxicol Environ Health A. 2013;76(2):107–119.
   PubMed Web of Science ®Google Scholar
• Montag J, Hitt R, Opitz L, et al. Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease. Mol Neurodegener. 2009;4:36.
   PubMed Web of Science ®Google Scholar
• Seo GJ, Fink LH, O’Hara B, et al. Evolutionarily conserved function of a viral microRNA. J Virol. 2008;82(20):9823–9828.
   PubMed Web of Science ®Google Scholar
• Melar-New M, Laimins LA. Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins. J Virol. 2010;84(10):5212–5221.
   PubMed Web of Science ®Google Scholar
• Gupta A, Gartner JJ, Sethupathy P, et al. Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nature. 2006;442(7098):82–85.
   PubMed Web of Science ®Google Scholar
• Ura S, Honda M, Yamashita T, et al. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology. 2009;49(4):1098–1112.
   PubMed Web of Science ®Google Scholar
• Omoto S, Fujii YR. Regulation of human immunodeficiency virus 1 transcription by nef microRNA. J Gen Virol. 2005;86(Pt 3):751–755.
   PubMedGoogle Scholar
• Dunn W, Trang P, Zhong Q, et al. Human cytomegalovirus expresses novel microRNAs during productive viral infection. Cell Microbiol. 2005;7(11):1684–1695.
   PubMed Web of Science ®Google Scholar
• Sullivan CS, Grundhoff AT, Tevethia S, et al. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature. 2005;435(7042):682–686.
   PubMed Web of Science ®Google Scholar
• Seo GJ, Chen CJ, Sullivan CS. Merkel cell polyomavirus encodes a microRNA with the ability to autoregulate viral gene expression. Virology. 2009;383(2):183–187.
   PubMed Web of Science ®Google Scholar
• Qin ZL, Zhao P, Zhang XL, et al. Silencing of SARS-CoV spike gene by small interfering RNA in HEK 293T cells. Biochem Biophys Res Commun. 2004;324(4):1186–1193.
   PubMed Web of Science ®Google Scholar
• Rebolledo-Mendez JD, Vaishnav RA, Cooper NG, et al. Cross-kingdom sequence similarities between human micro-RNAs and plant viruses. Commun Integr Biol. 2013;6(5):e24951.
   PubMedGoogle Scholar
• Vaschetto LM. A putative 20-nt miRNA in COVID-19 aligns to both the forward and reverse complementary strands of hsa-mir-8055 involved in T-cell response. 2020.
   Google Scholar
• Sardar R, Satish D, Birla S, et al. Comparative analyses of SAR-CoV2 genomes from different geographical locations and other coronavirus family genomes reveals unique features potentially consequential to host-virus interaction and pathogenesis. BioRxiv. 2020;3(21):001586.
   Google Scholar
• Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4):e21.
   PubMed Web of Science ®Google Scholar
• Chen LJ, Xu R, Yu HM, et al. The ACE2/apelin signaling, microRNAs, and Hypertension. Int J Hypertens. 2015;896861:2015.
   Google Scholar
• Bartel DP. Metazoan MicroRNAs. Cell. 2018;173(1):20–51.
   PubMed Web of Science ®Google Scholar
• Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010;11(9):597–610.
   PubMed Web of Science ®Google Scholar
• Zhdanov VP. Intracellular miRNA or siRNA delivery and function. Biosystems. 2018;171:20–25.
   PubMed Web of Science ®Google Scholar
• Rakhmetullina A, Ivashchenko A, Akimniyazova A, et al. The miRNA complexes against coronaviruses COVID-19, SARS-CoV, And MERS-CoV. (2020).
   Google Scholar
• Saçar Demirci MD, Adan A. Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection. BioRxiv. 2020;3(15):992438..
   Google Scholar
• Zhang S, Li J, Li J, et al. Up-regulation of microRNA-203 in influenza A virus infection inhibits viral replication by targeting DR1. Sci Rep. 2018;8(1):6797.
   PubMedGoogle Scholar
• Komatsu K, Miyashita T, Hang H, et al. Human homologue of S. pombe Rad9 interacts with BCL-2/BCL-xL and promotes apoptosis. Nat Cell Biol. 2000;2(1):1–6.
   PubMed Web of Science ®Google Scholar
• Liu Z, Wang J, Xu Y, et al. Implications of the virus-encoded miRNA and host miRNA in the pathogenicity of SARS-CoV-2. ArXiv. 2020; 2004:04874.
   Google Scholar
• Guterres A, de Azeredo Lima CH, Miranda RL, et al. What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19? Infect Genet Evol. 2020;85:104417.
   PubMed Web of Science ®Google Scholar
• Arisan ED, Dart A, Grant GH, et al. The prediction of miRNAs in SARS-CoV-2 genomes: hsa-mir databases identify 7 key miRs linked to host responses and virus pathogenicity-related KEGG pathways significant for comorbidities. Viruses. 2020;12:6.
   Web of Science ®Google Scholar
• Hosseini Rad Sm A, McLellan AD. Implications of SARS-CoV-2 mutations for genomic RNA structure and host microRNA targeting. Int J Mol Sci. 2020;21:13.
   Web of Science ®Google Scholar
• Scaria V, Hariharan M, Maiti S, et al. Host-virus interaction: a new role for microRNAs. Retrovirology. 2006;3:68.
   PubMed Web of Science ®Google Scholar
• Qin C, Wang J, Wei Q, et al. An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus. J Pathol. 2005;206(3):251–259.
   PubMed Web of Science ®Google Scholar
• Moens U. Silencing viral microRNA as a novel antiviral therapy? J Biomed Biotechnol. 2009;2009:419539.
   PubMedGoogle Scholar
• Trobaugh DW, Klimstra WB. MicroRNA regulation of RNA virus replication and pathogenesis. Trends Mol Med. 2017;23(1):80–93.
   PubMed Web of Science ®Google Scholar
• Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16(3):203–222.
   PubMed Web of Science ®Google Scholar
• Fu Y, Chen J, Huang Z. Recent progress in microRNA-based delivery systems for the treatment of human disease. ExRNA. 2019;1(1):24.
   Google Scholar
• Lee SWL, Paoletti C, Campisi M, et al. MicroRNA delivery through nanoparticles. J Control Release. 2019;313:80–95.
   PubMed Web of Science ®Google Scholar
• Fernandez-Piñeiro I, Badiola I, Sanchez A. Nanocarriers for microRNA delivery in cancer medicine. Biotechnol Adv. 2017;35(3):350–360.
   PubMed Web of Science ®Google Scholar
• Bai Z, Wei J, Yu C, et al. Non-viral nanocarriers for intracellular delivery of microRNA therapeutics. Journal Materials Chem. B. 2019;7(8):1209–1225.
   PubMed Web of Science ®Google Scholar
• Yang N. An overview of viral and nonviral delivery systems for microRNA. Int J Pharm Investig. 2015;5(4):179–181.
   PubMed Web of Science ®Google Scholar
• Ganju A, Khan S, Hafeez BB, et al. miRNA nanotherapeutics for cancer. Drug Discov Today. 2017;22(2):424–432.
   PubMed Web of Science ®Google Scholar
• Setua S, Khan S, Yallapu MM, et al. Restitution of tumor suppressor microRNA-145 using magnetic nanoformulation for pancreatic cancer therapy. J Gastrointest Surg. 2017;21(1):94–105.
   PubMed Web of Science ®Google Scholar
• Nagesh PKB, Chowdhury P, Hatami E, et al. miRNA-205 nanoformulation sensitizes prostate cancer cells to chemotherapy. Cancers (Basel). 2018;10:9.
   PubMed Web of Science ®Google Scholar
• Baumann V, Winkler J. miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents. Future Med Chem. 2014;6(17):1967–1984.
   PubMed Web of Science ®Google Scholar
• Martirosyan A, Olesen MJ, Howard KA. Chitosan-based nanoparticles for mucosal delivery of RNAi therapeutics. Adv Genet. 2014;88:325–352.
   PubMed Web of Science ®Google Scholar
• Deng F, He S, Cui S, et al. A molecular targeted immunotherapeutic strategy for ulcerative colitis via dual-targeting nanoparticles delivering miR-146b to intestinal macrophages. J Crohn’s Colitis. 2019;13(4):482–494.
   Google Scholar
• Arntz OJ, Pieters BC, Oliveira MC, et al. Oral administration of bovine milk derived extracellular vesicles attenuates arthritis in two mouse models. Mol Nutr Food Res. 2015;59(9):1701–1712.
   PubMed Web of Science ®Google Scholar
• Mahidhara G, Kanwar RK, Roy K, et al. Oral administration of iron-saturated bovine lactoferrin-loaded ceramic nanocapsules for breast cancer therapy and influence on iron and calcium metabolism. Int J Nanomedicine. 2015;10:4081–4098.
   PubMed Web of Science ®Google Scholar
• Beuzelin D, Pitard B, Kaeffer B. Oral delivery of miRNA with lipidic aminoglycoside derivatives in the breastfed rat. Front Physiol. 2019;10:1037.
   PubMed Web of Science ®Google Scholar
• Zou D, Ganugula R, Arora M, et al. Oral delivery of nanoparticle urolithin A normalizes cellular stress and improves survival in mouse model of cisplatin-induced AKI. Am J Physiol Renal Physiol. 2019;317(5):F1255–f1264.
   PubMed Web of Science ®Google Scholar